Summary A retrospective, population-based study was 
Breast cancer is the commonest female malignancy in the UK, with approximately 25 000 new cases annually, of whom about 15 000 will ultimately die from the disease (OPCS, 1994) . Although mainly affecting women over the age of 50 years, 20-25% of cases occur below this age (Thames Cancer Registry, 1993; Chouillet et al., 1994) . Breast cancer is the leading cause of death in women aged 35-49 years in the UK, accounting for about 20% of all deaths in this age group (OPCS, 1993) . The UK national breast cancer screening programme involves women over the age of 50 years only. Thus earlier detection of symptomatic disease and more effective management are necessary if survival is to be improved in younger women.
Treatment of breast cancer has changed considerably in the past 20 years. Whereas a radical or modified radical mastectomy used to be the standard treatment, it is now clear that in appropriate cases breast-conserving treatment achieves equivalent long-term survival rates (Veronesi et al., 1981; Sarrazin et al., 1983; Fisher et al., 1985; Van Dongen et al., 1991; Lichter et al., 1992) . Furthermore, in the past 10 years it has become increasingly apparent that systemic adjuvant therapy following surgery leads to a reduction in recurrence rates and mortality (Early Breast Cancer Trialists' Collaborative Group, 1992) .
In October 1986 a consensus statement on the treatment of operable breast cancer was published (King's Fund Forum, 1986) . Topics included the appropriate assessment of women suspected of having breast cancer; the best forms of initial local treatment and systemic treatment; the advantages and disadvantages of different degrees of patient participation in treatment decisions, and how services for treating breast cancer should be organised most effectively.
Against this background we analysed the primary treatment given to all women resident in the South East Thames Health Region who were diagnosed as having invasive breast cancer aged less than 50 years between January 1984 and December 1988. This period was chosen as a time of likely change in management of breast cancer, following publication of early trial results concerning the efficacy of breast-conserving therapy and the possible benefits of systemic adjuvant therapy. Selection of this period also gave adequate follow-up time to assess the outcome of such management.
Methods
The Thames Cancer Registry (TCR) supplied anonymised data for all patients aged less than 50 years registered with breast cancer for the period 1 January 1984 to 31 December 1988 who were resident in the South East Thames Regional Health Authority (SETHRA). Each patient record comprised 35 data items collected by registry peripatetic clerks who visit the hospitals in the four Thames regions and collate data on regional residents treated in other regions. Age and district of residence were known for all patients.
The The number of registrations in each district of residence over the 5 year period ranged from 78 to 163. The registration rates varied from 1.42 to 2.14 per 10 000 women in the age range 35-49 years in each district per annum (P= 0.07). For the three inner London districts, the incidence was 1.80, compared with 1.76 for the four outer London districts and 1.94 for the eight non-metropolitan districts (P= 0.26) .
Primary surgery A total of 1485 (84.5%) of the 1757 patients were recorded as having undergone at least one surgical procedure related to the breast and/or axillary lymph nodes. These operations were performed in at least 90 different hospitals. Of all the women, 396 (27%) underwent surgery at a teaching hospital, three of which are located in SETRHA and seven in adjacent regions. More than 50 women underwent breast surgery in each of the three teaching hospitals within SETRHA and the other seven teaching hospitals are known from Thames Cancer Registry data (not shown) to have comparably large breast cancer practices. A further 928 (62%) women underwent surgery in a total of 39 non-teaching hospitals within SETRHA (Table I ). The remaining 161 (11%) patients were treated surgically in a total of 14 NHS non-teaching hospitals outside SE Thames (23 patients) or in private institutions (138 patients). The 1324 women shown in Table  I , who were treated in SETRHA hospitals or in teaching hospitals in adjacent regions, form the basis of the subsequent detailed analysis of treatment patterns (group A).
The type of hospital to which the 1324 patients were initially referred depended to a large extent on their district of residence. Eight of the 15 districts within SE Thames are located more than 20 miles from any teaching hospital. Only 32 of 742 (4.3%) women from these districts underwent primary surgery at a teaching hospital. A further four districts have no teaching hospital within the district, but are within 20 miles of one. Primary surgery was undertaken in a teaching hospital in 179/352 (51%) of cases from these districts. One district has both a teaching hospital and a nonteaching hospital and the remaining two districts have a teaching hospital only. Referrals to a teaching hospital for residents of these three districts were 41/83 (49%), 75/78 (96%), and 69/69 (100%) respectively.
The extent of surgery varied considerably between hospitals, with major changes in practice being observed over the 5 year period. The proportion of women undergoing mastectomy is shown in Table I , with higher mastectomy rates in teaching hospitals (42%) than non-teaching hospitals (35%, P= 0.01). Mastectomy was undertaken in 52% of patients who presented in 1984, compared with only 28% of patients who presented in 1988 (P<0.0001). The changes in practice in teaching and non-teaching hospitals over time are shown in Table II . In both teaching hospitals and in nonteaching hospitals the decrease in mastectomy rates over time was significant (P=0.02 and P<0.0001 respectively).
Only 560 (42%) of the women who underwent surgery had any form of operation on the axillary lymph nodes recorded by the Registry. The proportion of women treated in teaching hospitals who underwent axillary surgery (65%) was twice that for women in non-teaching hospitals (32.5%, P< 0.0001). The proportion of women undergoing any The influence of demographic factors (age and district of residence) and tumour-related factors (extent of disease and histology) on survival was assessed for the whole patient group (n = 1702), excluding those diagnosed through death certification only (n = 55). Both extent of disease (P<0.0001) and histology (P<0.0001) were highly significant predictors of survival, patients with localised disease and those with specific histological subtypes of breast cancer having the best outcome (Table VI) . Neither age (P=0.13) nor district of residence (P=0.14) influenced survival significantly, though considerable differences in hazard ratios were observed between the districts with highest and lowest mortality (1.00 and 1.98 respectively).
A second analysis was undertaken restricted to the 1324 patients in group A. Demographic factors (age and district of residence) and type of hospital were included in the model. As differences in extent of disease and histological coding between teaching and non-teaching hospitals might be due to differences in surgical procedure and pathological expertise (see above), these factors were not included in this model. Among these surgically treated cases only age had a significant influence on survival, with patients under 35 years faring worse (P = 0.02).
Discussion
Most reports on the management and outcome of patients with breast cancer in the UK relate to women treated in specialist centres or those treated in multicentre trials. One previous report compared the treatment and outcome of women managed at two centres where radiotherapy and chemotherapy were available, one in an urban teaching district, the other a rural non-teaching district (Basnett et al., 1992) . That study, involving a total of 999 women, 235 of whom were aged 50 years or less, appeared to show significantly worse survival for women treated in the nonteaching district (odds of death 1.46, P= 0.0009). The authors, however, advised that this finding should be treated with caution and recommended that cancer registries should be used as a tool for audit. A recent study from the Thames Cancer Registry examined the treatment given to 334 residents of the four Thames regions who were diagnosed in early 1990, 86 of whom were aged less than 50 years (Chouillet et al., 1994) . However, differences in management between treatment centres were not analysed and survival data were not shown.
In the current study, covering a defined geographical population, we have examined the treatment and outcome for women under 50 years. We were particularly interested in this age group as there is a strong rationale for undertaking axillary surgery in order to obtain prognostic information that may be of importance in giving advice related to the use of adjuvant systemic therapy. To the best of our knowledge this study is the first in which the number of patients treated (1994) showed that retrospective reconstruction of staging (I-IV) is only possible in about 50% of cases even after detailed scrutiny of case records. We therefore used the staging classification adopted by Thames Cancer Registry, which is based on pathological information when available and clinical data for the remainder. This undoubtedly underestimates the true incidence of node positivity, which might be expected to be approximately 50%, compared with 19% classified as having 'local disease and nodes' in the current study. We also adopted a simple classification of treatments to minimise errors due to differences in recording of surgical procedures by surgeons. Women in the UK with suspected breast cancer are normally referred to a general surgeon for assessment. As shown in this study, breast surgery was undertaken in 42 NHS hospitals in SETRHA during the 5 year study period. The short study period of only a few weeks covered in the report by Chouillet et al. (1994) may have led to a considerable underestimate of the total number of hospitals managing primary breast cancer (reported as 81 for the four Thames regions) as those hospitals managing only a few cases annually may well not have diagnosed any patients during that period.
In the current study almost 90% of the patients who underwent surgery received this in NHS hospitals within the region or in teaching hospitals in adjacent regions. Of these, 58% received their surgical treatment in a teaching hospital or in one of five non-teaching hospitals with a relatively large breast cancer practice (i.e. on average more than ten cases in this age group per annum). A further 34% of patients underwent surgery in a total of 15 hospitals, each of which treated between two and ten patients in this age group annually. The remaining 7% of the patient population underwent surgery in a total of 19 hospitals, each of which dealt with an average of less than two such patients annually. Although these figures apply only to residents of SE Thames region, it is unlikely that significant cross boundary flows occurred with patients being referred to SE Thames hospitals other than to teaching hospitals.
Referral to a teaching hospital or to a non-teaching hospital depended largely on geographical access. Almost all patients living in districts situated more than 20 miles from a teaching hospital underwent primary surgery in a nonteaching hospital. Conversely, the large majority of women living in the districts served directly by a teaching hospital underwent treatment there. For women resident in the four districts situated an intermediate distance from a teaching hospital it is possible that referral may have been affected by casemix (e.g. tumour size). However, it seems more likely that individual GPs in these districts selectively refer the majority of women with breast problems to one preferred centre. In any case, when women in these four districts were excluded from the analysis, the differences in surgical practice observed between hospital types remained highly significant. (Carter et al., 1989) .
As far as the assessment of women with breast cancer is concerned, involvement of axillary lymph nodes is well recognised as the most important determinant of prognosis, followed by histological type and grade (Carter et al., 1989; Bloom and Richardson, 1957; O'Reilly et al., 1990) . Information regarding axillary nodal status may be of particular importance in women under 50 years, as this may be used in deciding whether to recommend adjuvant chemotherapy. The consensus statement clearly recommended that axillary nodes should be sampled at the time of breast surgery. In practice, only 42% of women with operable breast cancer in this study were recorded as having any form of axillary surgery. Axillary surgery was performed less frequently in district general hospitals and the proportion of patients receiving such assessment actually fell after the publication of the consensus statement. The less frequent use of axillary surgery in non-teaching hospitals is in direct contrast to the findings reported by Basnett et al. for the same age group (1992) . The low overall rate of axillary surgery is, however, similar to that reported by other studies (Chouillet et al., 1994; Basnett et al., 1992) . It al., 1989, 1992 al., 1981; Fisher et al., 1983; Anonymous, 1984; Baum et al., 1983 Baum et al., , 1985 . The King's Fund consensus statement made it clear that (i) combination chemotherapy reduces the death rate in nodepositive patients aged less than 50 years; (ii) destroying ovarian function had a similar effect on mortality; (iii) there was some evidence of a reduced relapse rate with tamoxifen.
In practice, the use of adjuvant chemotherapy was very limited in SE Thames at least up to 1988. Indeed, most treated cases were confined to one hospital in which trials of chemotherapy were being conducted. Tamoxifen was, however, quite widely used, particularly in district general hospitals. 1986 (McCarthy and Bore, 1991) . As in our study, the authors noted that a significant number of patients received lumpectomy without radiotherapy. Chemotherapy was given to 27% and tamoxifen to 26% of women under 50 years (compared with 12% and 22% respectively in our teaching hospital group).
In conclusion, this study has demonstrated that primary treatment for women aged less than 50 years is provided in a multitude of different hospitals, the majority of which treat only very limited numbers of patients. Treatment given to patients varied significantly between hospitals. While this has not been shown to have an adverse effect on survival, a high proportion of women managed outside teaching hospitals are receiving a form of surgical management that has never been validated by randomised controlled trials. The lack of pathological information related to nodal status almost certainly leads to inappropriate recommendations regarding adjuvant treatment.
